Moderna entered 2 types of contracts with the US Government for Spikevax injection.
Posted BY: | NwoReport
Here is a high-level review of the manufacturing contracts between the US DOD and Moderna.
Moderna’s injection, mRNA-1273 is co-owned with the US Government, as the company has been funded by defense research grants for years and also received intellectual property transfers from the US Government, in addition to preclinical and clinical research work conducted for Moderna by the NIH Vaccine Research Center. The NIH and Moderna each have a separate Investigational New Drug number for this product.
Trending: Patrick Byrne Drops Damning Article About Smartmatic
Moderna entered 2 types of contracts with the US Government for Spikevax injection:
- “Vaccine” contract and amendments that specifies R&D projects that the US Government ordered and paid for. Note that in Pfizer’s case, no R&D activities were ordered or paid for by the US Government, as these were excluded from the scope of the contract.
- “Manufacturing” contract(s) that ordered large-scale manufacturing. This is different from Pfizer manufacturing contracts as the words “demonstration” and “prototype” are not used. I believe this is because OTA contracts must be for prototypes but FAR contracting doesn’t have to be.
Note on redactions. In both Moderna and Pfizer’s contracts, many areas are redacted indicating a reason for redaction – the “redaction codes.” Redacted content has been given codes b (4) and b (6), standing for:
(b) (4) Disclosure of information that would affect the application of advanced technology in a U.S. weapons system,
(b) (6) Disclosure of information, including information of foreign governments, that would cause serious harm to relations between the United States and a foreign government or to ongoing diplomatic activities of the United States.